US Orphan Drug Market Outlook 2018
Reportstack, provider of premium market research reports announces the addition of US Orphan Drug Market Outlook 2018 market report to its offering
n the largest market for orphan drugs, USA, there was a shortage of adequate therapies for treating many rare diseases. These therapies were not developed as companies did not expect these drugs to be highly profitable. Hence there was a lack of interest and thus investment on the part of pharma companies in the USA. Therefore, the FDA...
View full press release